MARKET

EVFM

EVFM

Evofem Bioscienc
OTCMQB
0.011
+0.001
+10.20%
Closed 15:52 07/12 EDT
OPEN
0.0099
PREV CLOSE
0.0098
HIGH
0.011
LOW
0.0093
VOLUME
162.38K
TURNOVER
1.68K
52 WEEK HIGH
196.25
52 WEEK LOW
0.0060
MARKET CAP
670.25K
P/E (TTM)
-0.0018
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at EVFM last week (0701-0705)?
Weekly Report · 5d ago
Weekly Report: what happened at EVFM last week (0624-0628)?
Weekly Report · 07/01 10:46
Weekly Report: what happened at EVFM last week (0617-0621)?
Weekly Report · 06/24 10:51
Weekly Report: what happened at EVFM last week (0610-0614)?
Weekly Report · 06/17 10:45
Evofem gains on new U.S. patent covering Phexxi composition of matter
Evofem gains on new U.S. Patent covering Phexxi composition of matter. Evofem Biosciences shares rose +3.45% to $0.01. The company has secured a new patent covering composition and methods for contraception with a vaginal gel.
Seeking Alpha · 06/11 15:00
Weekly Report: what happened at EVFM last week (0603-0607)?
Weekly Report · 06/10 10:46
Weekly Report: what happened at EVFM last week (0527-0531)?
Weekly Report · 06/03 10:48
Weekly Report: what happened at EVFM last week (0520-0524)?
Weekly Report · 05/27 10:52
More
About EVFM
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. The Company is commercializing advanced products to address unmet needs in women’s sexual and reproductive health. The Company’s first FDA-approved product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Phexxi is an advanced gel that works to prevent pregnancy without the use of hormones. Phexxi prevents pregnancy by reducing sperm motility, inhibiting sperm from reaching the ovum to form a zygote. Phexxi is designed to address underserved and unmet needs in the birth control market. Additionally, the Company offers women direct access to Phexxi through its telehealth partner. Using this platform, women can have a telehealth visit with a health care provider (HCP) to determine their eligibility for a Phexxi prescription.

Webull offers Evofem Biosciences Inc stock information, including OTCMQB: EVFM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVFM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EVFM stock methods without spending real money on the virtual paper trading platform.